Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

ALK5 inhibitor effective in nephritis-induced renal fibrosis in rats

June 21, 2005

Phase II data supports the use of Sanctura XR for overactive bladder

June 20, 2005

Effective control of serum phosphorus levels with lanthanum carbonate in hemodialysis patients

June 17, 2005

Silodosin enters phase III in U.S. for BPH

June 15, 2005

Acarbose shows promise in the treatment of renal disease

June 15, 2005

MCI-196 decreases serum phosphate and cholesterol levels of hemodialysis patients

June 14, 2005

Harnal D launched in Japan

June 14, 2005

NX-1207 shows long-term efficacy in improving the symptoms of BPH

June 14, 2005

PhosLo studied in chronic kidney disease patients

June 13, 2005

Rho kinase inhibition prevents renal and cardiac tissue fibrosis

June 10, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...